Recent Updates
Recently added Catalysts

Chronocort: fasted

Phase 1

Healthy | Small molecule | Other |Neurocrine Biosciences, Inc.|Last Updated: May 4, 2022

Success Probability
Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
Premium
Market & Valuation
rNPV $3.2B
Market Size $9.4B
Revenue Basis $1.6B
Competitors 6
Premium
Trial Design
RandomizedACTIVE_CONTROLLEDBiomarker
Total Trials1
Total Enrollment18
FDA Designations
No designations recorded
Clinical Trials (1)
NCT IDTitlePhaseStatusEnrollmentVelocityDesignStartCompletionLast UpdatedSitesCountries
NCT02408068Effect of Slow Release Hydrocortisone on Fed & Fasting Volunteers; Immediate Release on Fasting OnlyPHASE1 COMPLETED 18Jan 1, 2015Mar 1, 2015May 4, 2022 -
Unlock Drug Trial Details
Study Endpoints
Primary Endpoints
Chronocort Cmax
24 hours

Comparison of fed and fasted Chronocort Cmax for serum cortisol.

Comparison of Fed and Fasted Chronocort AUC0-t
24 hours (at 0h, then 0.5h, 1h, 1.5h, 2h, 2.5h, 3h, 3.5h, 4h, 4.5h, 5h, 5.5h, 6h, 6.5h, 7h, 7.5h, 8h, 9h, 10h, 11h, 12h, 13h, 14h, 15h, 16h, 18h, 20h, 22h and 24h post-dose.)

Area under the curve from 0 to 24 hours for serum cortisol. Please note that the AUC0-t will be presented as a single figure (geometric mean) to represent exposure over time. N.B., the sampling points for Hydrocortisone are as follows: 0h, 0.25h, 0.5h, 0.75h, 1h, 1.5h, 2h, 2.5h, 3h, 4h, 5h, 6h, 8h, 10h and 12h post-dose. However, the results for Hydrocortisone will not be incorporated into the analysis for this outcome measure.

Comparison of Fed and Fasted Chronocort Tmax
24 hours

Comparison of Fed and Fasted Chronocort based on the time to achive the maximum concentration of serum cortisol

Bioavailability of Chronocort® vs Hydrocortisone Tablets - Cmax
24 hours

Evaluation of the relative bioavailability of Chronocort® and immediate release hydrocortisone at a single dose of 20 mg in the fasted state by Cmax

Bioavailability of Chronocort® vs Hydrocortisone Tablets - Fasted Using AUC0-t
24 hours

To evaluate the relative bioavailability of Chronocort® and immediate release hydrocortisone at a single dose of 20 mg in the fasted state using area under the curve

Bioavailability of Chronocort® vs Hydrocortisone Tablets - Fasted Using Tmax.
24 hours

To evaluate the relative bioavailability of Chronocort® and immediate release hydrocortisone at a single dose of 20 mg in the fasted state using Tmax.

Unlock Study Endpoints
Study Design & Arms
AllocationRANDOMIZED
MaskingNONE
ModelCROSSOVER
PurposeBASIC_SCIENCE
Treatment Arms
ArmTypeDescription
Chronocort : fedACTIVE_COMPARATORVolunteers will be admitted, take dexamethasone at 22.00hrs, fast overnight, and receive a high fat, high calorie breakfast on the morning of Day 1. Thirty minutes after the start of the breakfast they will receive 20mg of modified release hydrocortisone with 200 millilitres of water, and no further food for 4 hours, water will be allowed from 1 hour after the food. Further dexamethasone doses will be given at 06:00, 12:00, 18:00 and 22:00 hours on Day 1. One baseline pharmacokinetics (PK) sample will be taken starting prior to the dose and then over 24 hours (29 samples).
Immediate release hydrocortisone: fastedACTIVE_COMPARATORVolunteers will be admitted, take dexamethasone at 22.00hrs, fast overnight, and take 20mg immediate release hydrocortisone with 200 millilitres of water on the morning of Day 1. Water will be allowed 1hr after the study drug, but no food for at least 4hrs post dose. Further dexamethasone doses will be given at 06:00, 12:00 and 18:00 hours on Day 1. One baseline pharmacokinetics (PK) sample will be taken prior to the dose, and then afterwards for over a 12 hour period (16 samples)
Chronocort: fastedACTIVE_COMPARATORVolunteers will be admitted, take dexamethasone at 22.00hrs, fast overnight, and take 20mg modified release hydrocortisone with 200millilitres of water on the morning of Day 1. Water will be allowed 1hr after the dose, but no food for at least 4hrs post dose. Further dexamethasone doses will be given at 06:00, 12:00, 18:00 and 22:00 hours on Day 1. One baseline pharmacokinetics (PK) sample will be taken prior to the dose, and then afterwards for over a 12 hour period (16 samples)
Interventions
NameTypeDescription
DexamethasoneDRUGDexamethasone used to suppress endogenous cortisol secretion
Chronocort: fastedDRUGsingle dose of 20mg modified release hydrocortisone in the absence of food
Immediate release hydrocortisone: fastedDRUGsingle dose of 20mg immediate release hydrocortisone in the absence of food
Chronocort: fedDRUGsingle dose of 20mg modified release hydrocortisone in the presence of food
Unlock Study Design Details
Eligibility Criteria
Age Range18 Years — 60 Years
SexMALE
Healthy VolunteersYes

Inclusion Criteria: * Healthy male volunteers between 18 and 60 years of age, inclusive (at screening) * A body mass index of 21-28 (inclusive). * No clinically significant abnormal serum biochemistry, haematology and urine examination values * A negative urinary drugs of abuse screen. A positive a...

Unlock Eligibility Criteria